Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Cytosorbents Corp changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 58 | 1 | 53 | −4 |
| Shares | 15.2M | 42.3K | 15.2M | +49.9K (+0.3%) |
| Value | $54.7M | $151.9K | $28.7M | −$25.9M (−47.4%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Cytosorbents Corp at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CIBC Private Wealth Group, LLC | 122,649 | $230.6K | 0.00% |
| HRT Financial LP | 10,256 | $19.0K | 0.00% |
| US Bancorp | 10,000 | $18.8K | 0.00% |
| Barclays PLC | 5,577 | $10.5K | 0.00% |
| Comerica Bank | 258 | $485 | 0.00% |
| Allworth Financial LP | 37 | $70 | 0.00% |
| Qube Research & Technologies Ltd | 1 | $2 | 0.00% |
Sold out (11)
Institutions that held Cytosorbents Corp at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Truist Financial Corp | 45,000 | $161.6K |
| Deutsche Bank AG | 17,681 | $63.5K |
| Houlihan Financial Resource Group, Ltd. | 18,600 | $59.0K |
| AE Wealth Management LLC | 13,783 | $49.5K |
| B.O.S.S. Retirement Advisors, LLC | 13,491 | $48.4K |
| Susquehanna International Group, LLP | 10,820 | $38.8K |
| TCTC Holdings, LLC | 9,000 | $32.3K |
| Acadian Asset Management LLC | 9,059 | $32.0K |
| Harbor Capital Advisors, Inc. | 6,482 | $23.3K |
| Group One Trading, L.P. | 4,263 | $15.3K |
| Rhumbline Advisers | 1,897 | $6.81K |
Not filed for Q3 2023 yet (1)
Institutions that held Cytosorbents Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cowen Prime Advisors LLC | 42,301 | $151.9K |